SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-142966
Filing Date
2022-05-06
Accepted
2022-05-06 07:15:45
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d357008d424b5.htm 424B5 405851
2 GRAPHIC g357008g04f41.jpg GRAPHIC 46601
3 GRAPHIC g357008g06r23.jpg GRAPHIC 32904
4 GRAPHIC g357008g22s22.jpg GRAPHIC 26763
  Complete submission text file 0001193125-22-142966.txt   545882
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-239706 | Film No.: 22898825
SIC: 2834 Pharmaceutical Preparations